Who invested in MiroBio?
MiroBio's investors include Oxford Science Enterprises, Samsara BioCapital, SR One, OrbiMed and Advent Life Sciences Llp.

United Kingdom · Series B startup
Funding summaryUpdated 26 Oct 2026
$144Mraised across 3 rounds since 2019, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Reported by Innovation
MiroBio filed 4 raises, $59M in all. Filings say how much was sold and to how many investors; they never name the investors.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
MiroBio's investors include Oxford Science Enterprises, Samsara BioCapital, SR One, OrbiMed and Advent Life Sciences Llp.
MiroBio has raised $144M across 3 rounds since 2019.
MiroBio's most recent round was a Series B of $97M in Jun 2022.
Its most recent round, $97M in Jun 2022, is also its largest on record.
MiroBio's first round on record, in Oct 2019, was backed by Oxford Science Enterprises, Samsara BioCapital and SR One and 1 others.
MiroBio's latest named round is a Series B, in Jun 2022.
MiroBio is based in the United Kingdom.
Oxford Science Enterprises led the Undisclosed round in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.